Sollentuna, Sweden

Hong Li

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Stockholm, SE (2006)
  • Sollentuna, SE (2022)

Company Filing History:


Years Active: 2006-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Hong Li in PDGF-C Research

Introduction

Hong Li is a prominent inventor based in Sollentuna, Sweden, known for his contributions to medical research and innovation. With two patents to his name, he has developed significant advancements in the understanding and treatment of diseases associated with platelet-derived growth factor C (PDGF-C).

Latest Patents

Hong Li's latest patents reflect his dedication to advancing medical science. The first patent, titled "Methods and Compositions for PDGF-CC Inhibition," focuses on isolated antibodies that specifically interact with an epitope of PDGF-C. These antibodies have the potential to modulate PDGF-C activity, aiding in the study of cell functions and offering possibilities for treating diseases related to PDGF-C signaling pathways.

The second patent, "Non-Human Transgenic Animals Expressing Platelet-Derived Growth Factor C (PDGF-C) and Uses Thereof," introduces non-human transgenic animals that overexpress PDGF-C. These animals serve as valuable models for studying disease states characterized by the overexpression of PDGF-C and evaluating potential therapies aimed at such conditions.

Career Highlights

Throughout his career, Hong Li has collaborated with esteemed institutions to further his research. Notably, he has worked with the Ludwig Institute for Cancer Research Limited and Paracrine Therapeutics AB. His work has played a crucial role in enhancing our understanding of PDGF-C’s impact on cell behavior and its implications in various diseases.

Collaborations

Hong Li has collaborated with notable researchers such as Ulf Eriksson and Xuri Li. These partnerships have facilitated the advancement of innovative research in the field of cancer and regenerative medicine, fostering a collaborative environment that enriches the scientific community's understanding of PDGF-C.

Conclusion

Hong Li’s contributions to the understanding of PDGF-C not only enhance scientific knowledge but also pave the way for potential therapeutic interventions in diseases linked to this growth factor. His patents underscore the importance of innovation in medical research and illustrate the profound impact that dedicated inventors can have on healthcare advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…